NO980005L - Terapautiske midler og autoimmunsykdommer - Google Patents

Terapautiske midler og autoimmunsykdommer

Info

Publication number
NO980005L
NO980005L NO980005A NO980005A NO980005L NO 980005 L NO980005 L NO 980005L NO 980005 A NO980005 A NO 980005A NO 980005 A NO980005 A NO 980005A NO 980005 L NO980005 L NO 980005L
Authority
NO
Norway
Prior art keywords
agent
therapeutic agents
autoimmune diseases
etx
ctx
Prior art date
Application number
NO980005A
Other languages
English (en)
Other versions
NO980005D0 (no
NO319747B1 (no
Inventor
Neil Andrew Williams
Timothy Raymond Hirst
Toufic Osman Nashar
Original Assignee
Oratol Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oratol Ltd filed Critical Oratol Ltd
Publication of NO980005D0 publication Critical patent/NO980005D0/no
Publication of NO980005L publication Critical patent/NO980005L/no
Publication of NO319747B1 publication Critical patent/NO319747B1/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/24—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • C07K14/245—Escherichia (G)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/868—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving autoimmunity, allergy, immediate hypersensitivity, delayed hypersensitivity, immunosuppression, or immunotolerance

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Immunology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO19980005A 1995-07-05 1998-01-02 Anvendelse av et middel for fremstilling av et medikament for forebyggelse og/eller behandling av en autoimmun sykdom eller human T-celleleukemi samt transplantatavvisning eller GVDH, farmasoytisk preparat samt sett. NO319747B1 (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9513733.7A GB9513733D0 (en) 1995-07-05 1995-07-05 Therapeutic agents
PCT/GB1996/001614 WO1997002045A1 (en) 1995-07-05 1996-07-05 Therapeutic agents and autoimmune diseases

Publications (3)

Publication Number Publication Date
NO980005D0 NO980005D0 (no) 1998-01-02
NO980005L true NO980005L (no) 1998-03-05
NO319747B1 NO319747B1 (no) 2005-09-12

Family

ID=10777189

Family Applications (1)

Application Number Title Priority Date Filing Date
NO19980005A NO319747B1 (no) 1995-07-05 1998-01-02 Anvendelse av et middel for fremstilling av et medikament for forebyggelse og/eller behandling av en autoimmun sykdom eller human T-celleleukemi samt transplantatavvisning eller GVDH, farmasoytisk preparat samt sett.

Country Status (23)

Country Link
US (1) US6287563B1 (no)
EP (1) EP0841939B1 (no)
JP (1) JP4024298B2 (no)
KR (1) KR100452000B1 (no)
CN (1) CN1313150C (no)
AT (1) ATE275968T1 (no)
AU (1) AU724516B2 (no)
CA (1) CA2225788C (no)
CZ (1) CZ298670B6 (no)
DE (1) DE69633393T2 (no)
DK (1) DK0841939T3 (no)
ES (1) ES2229276T3 (no)
GB (1) GB9513733D0 (no)
HK (1) HK1006496A1 (no)
HU (1) HU224248B1 (no)
MX (1) MX9800241A (no)
NO (1) NO319747B1 (no)
NZ (1) NZ311762A (no)
PL (1) PL187266B1 (no)
PT (1) PT841939E (no)
RU (1) RU2203088C2 (no)
SI (1) SI0841939T1 (no)
WO (1) WO1997002045A1 (no)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9326174D0 (en) * 1993-12-22 1994-02-23 Biocine Sclavo Mucosal adjuvant
US20010036917A1 (en) 1995-07-05 2001-11-01 Williams Neil Andrew Therapeutic agents
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
GB9800487D0 (en) * 1998-01-09 1998-03-04 Oratol Limited Therapies
GB9801871D0 (en) * 1998-01-28 1998-03-25 Univ Bristol Therapies
EP1075274A2 (en) * 1998-05-08 2001-02-14 University Of Bristol Immunomodulators for vaccines
US7914791B1 (en) * 1998-05-08 2011-03-29 Trident Pharmaceuticals, Inc. Vaccine
US7041296B1 (en) 1999-11-12 2006-05-09 The United States Of America As Represented By The Department Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin B subunit
WO2001034175A2 (en) * 1999-11-12 2001-05-17 The Government Of The United States Of America, Asrepresented By The Secretary, Dept. Of Health And Human Services Methods of treating inflammatory bowel disease using cholera toxin b subunit
CA2358061A1 (en) * 2000-09-08 2002-03-08 Stemcell Technologies Inc. Novel antibody compositions for the negative selection of specific rat leukocyte subsets
GB0115382D0 (en) * 2001-06-22 2001-08-15 Univ Bristol Mutant
US20050084967A1 (en) 2002-06-28 2005-04-21 Xcyte Therapies, Inc. Compositions and methods for eliminating undesired subpopulations of T cells in patients with immunological defects related to autoimmunity and organ or hematopoietic stem cell transplantation
CA2899961C (en) * 2013-02-14 2022-08-09 Cornell University Methods to protect against and treat multiple sclerosis

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571787A (en) * 1993-07-30 1996-11-05 Myelos Corporation Prosaposin as a neurotrophic factor
US5681571A (en) * 1993-10-08 1997-10-28 Duotol Ab Immunological tolerance-inducing agent

Also Published As

Publication number Publication date
DK0841939T3 (da) 2005-01-24
CN1192693A (zh) 1998-09-09
JPH11508586A (ja) 1999-07-27
HU224248B1 (hu) 2005-07-28
RU2203088C2 (ru) 2003-04-27
AU6314296A (en) 1997-02-05
US6287563B1 (en) 2001-09-11
HUP9900147A3 (en) 1999-11-29
JP4024298B2 (ja) 2007-12-19
PL324424A1 (en) 1998-05-25
CA2225788C (en) 2010-09-21
CA2225788A1 (en) 1997-01-23
DE69633393D1 (de) 2004-10-21
HUP9900147A2 (hu) 1999-05-28
EP0841939B1 (en) 2004-09-15
NO980005D0 (no) 1998-01-02
KR100452000B1 (ko) 2004-11-20
CN1313150C (zh) 2007-05-02
ES2229276T3 (es) 2005-04-16
NO319747B1 (no) 2005-09-12
GB9513733D0 (en) 1995-09-06
KR19990028578A (ko) 1999-04-15
EP0841939A1 (en) 1998-05-20
HK1006496A1 (en) 1999-03-05
SI0841939T1 (en) 2005-04-30
DE69633393T2 (de) 2005-11-10
CZ1298A3 (cs) 1998-06-17
AU724516B2 (en) 2000-09-21
CZ298670B6 (cs) 2007-12-19
NZ311762A (en) 2001-04-27
WO1997002045A1 (en) 1997-01-23
ATE275968T1 (de) 2004-10-15
PT841939E (pt) 2005-02-28
MX9800241A (es) 1998-11-30
PL187266B1 (pl) 2004-06-30

Similar Documents

Publication Publication Date Title
DK0696205T3 (da) Anvendelse af neuro-afledte fetale cellelinier til transplantationsterapi
DK0841939T3 (da) Terapeutiske midler og autoimmune sygdomme
ES2142779T1 (es) Dispositivo de anclaje de osteosintesis vertebral posterior.
IS7770A (is) Hlutleysandi mótefni gegn GDF-8 og notkun theirra
GB9317104D0 (en) Therapeutic heterocycles
UA27035C2 (uk) Кристал білка, зшитого багатофуhкціоhальhим зшивальним агеhтом (варіаhти), пристрій, що містить кристал білка та спосіб отримаhhя аспартаму
DE59507920D1 (de) NEUE hIL-4-MUTANTENPROTEINE ALS ANTAGONISTEN ODER PARTIELLE AGONISTEN DES HUMANEN INTERLEUKIN 4
IT1238825B (it) Dispositivo per la correzione chirurgica dell'ametropia.
HUP9802091A2 (hu) Idegátültetés pluripotens neuroepiteliális sejtek alkalmazásával
IT9041503A0 (it) Dispositivo per la cura chirurgica dell'ametropia
DK0786004T3 (da) Kloning, ekspression og karakterisering af en hidtil ukendt form af phosphatidylinositol-3-kinase
BR0305018A (pt) Células dendrìticas tolerogênicas e usos terapêuticos para as mesmas
RU98101907A (ru) Терапевтические агенты и аутоимунные заболевания
ES2156215T3 (es) Utilizacion de un conjugado en el tratamiento y/o diagnostico de enfermedades inflamatorias.
BG101126A (en) The use of muramylpeptide compounds
ATE254595T1 (de) 2-amino-6-methyl-7-acetyl-tetralin und pharmazeutische zusammensetzungen zur vorbeugung und therapeutischen behandlung von entzündlichen und/oder autoimmunkrankheiten
DK0821593T3 (da) Konjugat af et aktivt middel, et protein og eventuelt et for kroppen ikke som fremmed anset nativt protein
ATE204018T1 (de) Zellwachstumsinhibitoren
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin
DK1137420T3 (da) Anvendelse af en kombination af et purin og en nitrogenmonooxiddonor til forebyggelse eller behandling af sexuel dysfunktion
MXPA02004704A (es) Analogos de acido hidroxieicosatetraenoico y sus metodos de uso en el tratamiento de trastornos de resequedad del ojo.
DE69432517D1 (de) Verfahren zur vorhersage der effektivität der behandlung von tumoren durch in-vitro bestimmung der überlebens- und vermehrungsfähigkeit
UA29707A (uk) Спосіб відновлення кісткових тканин при переломах
GR3027682T3 (en) 4-guanidinobutyramide for improving blood circulation.
UA12890A (uk) Спосіб акупуhктури

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees